Display options
Cite
Ellerington MC, Stevenson JC. Prevention of osteoporosis. Current recommendations. Drugs Aging. 1992;2(6):508-17doi: 10.2165/00002512-199202060-00006.
Ellerington, M. C., & Stevenson, J. C. (1992). Prevention of osteoporosis. Current recommendations. Drugs & aging, 2(6), 508-17. https://doi.org/10.2165/00002512-199202060-00006
Ellerington, M C, and Stevenson, J C. "Prevention of osteoporosis. Current recommendations." Drugs & aging vol. 2,6 (1992): 508-17. doi: https://doi.org/10.2165/00002512-199202060-00006
Ellerington MC, Stevenson JC. Prevention of osteoporosis. Current recommendations. Drugs Aging. 1992 Nov-Dec;2(6):508-17. doi: 10.2165/00002512-199202060-00006. PMID: 1493354.
Copy Download .nbib Format: NLM
Share it on
Full text links
Springer

Drugs Aging. 1992 Nov-Dec;2(6):508-17. doi: 10.2165/00002512-199202060-00006.

Prevention of osteoporosis. Current recommendations.

Drugs & aging

M C Ellerington, J C Stevenson

Affiliations

  1. Wynn Institute for Metabolic Research, London, England.

PMID: 1493354 DOI: 10.2165/00002512-199202060-00006

Abstract

Osteoporosis and its treatment have attracted much attention in recent years, especially since the widespread recognition of its association with the menopause. The resulting fractures are a cause of considerable morbidity and mortality in the elderly, and current costs of treating these patients has been estimated to be in excess of pounds 500 million per annum in the UK. As the causes of osteoporosis are now recognised the condition may be largely preventable, especially in women, and significant savings in health expenditure could be made if preventive methods are applied to those most at risk. The most well researched preventive treatment for osteoporosis is hormone replacement therapy (HRT) which offers additional benefits to those who choose it. Alternative methods currently under investigation for those who cannot or will not use HRT include those agents which inhibit the resorption of bone and those that stimulate the production of new bone. Treatment of established disease, i.e. attempts at increasing bone density in those with significant loss, is more difficult and methods so far investigated are not without risks and adverse effects. Furthermore, whether an increase in bone mineral density results in a reduced rate of fracture incidence has yet to be confirmed.

Similar articles

References

  1. Am J Obstet Gynecol. 1982 Nov 1;144(5):511-8 - PubMed
  2. Obstet Gynecol. 1984 Jun;63(6):759-63 - PubMed
  3. Metab Bone Dis Relat Res. 1981;3(4-5):279-87 - PubMed
  4. Endocrinology. 1987 Aug;121(2):819-21 - PubMed
  5. Clin Endocrinol (Oxf). 1989 Apr;30(4):435-42 - PubMed
  6. N Engl J Med. 1990 Mar 22;322(12):802-9 - PubMed
  7. Am J Obstet Gynecol. 1992 Mar;166(3):950-5 - PubMed
  8. Lancet. 1981 Mar 28;1(8222):693-5 - PubMed
  9. JAMA. 1967 Sep 18;201(12):918-22 - PubMed
  10. Am J Obstet Gynecol. 1987 Jun;156(6):1516-23 - PubMed
  11. Am J Med. 1988 Mar;84(3 Pt 1):401-8 - PubMed
  12. Eur J Clin Invest. 1980 Aug;10(4):273-9 - PubMed
  13. Clin Orthop Relat Res. 1987 Apr;(217):72-8 - PubMed
  14. Obstet Gynecol. 1979 Mar;53(3):277-81 - PubMed
  15. J Endocrinol. 1972 Oct;55(1):79-87 - PubMed
  16. Lancet. 1978 May 6;1(8071):961-2 - PubMed
  17. Scott Med J. 1981 Jan;26(1):72-80 - PubMed
  18. Bone Miner. 1989 Apr;6(1):77-86 - PubMed
  19. Lancet. 1988 Apr 23;1(8591):900-2 - PubMed
  20. Clin Sci Mol Med. 1978 Feb;54(2):193-5 - PubMed
  21. J Bone Miner Res. 1989 Aug;4(4):625-31 - PubMed
  22. Lancet. 1976 May 15;1(7968):1038-41 - PubMed
  23. Metabolism. 1984 Apr;33(4):295-303 - PubMed
  24. Ann Intern Med. 1989 Feb 15;110(4):267-74 - PubMed
  25. N Engl J Med. 1988 Nov 17;319(20):1313-7 - PubMed
  26. J Clin Invest. 1973 Nov;52(11):2800-8 - PubMed
  27. J Reprod Med. 1985 Oct;30(10 Suppl):814-20 - PubMed
  28. Lancet. 1978 Jun 24;1(8078):1325-7 - PubMed
  29. Circulation. 1987 Jun;75(6):1102-9 - PubMed
  30. Ann Intern Med. 1982 Nov;97(5):699-705 - PubMed
  31. Lancet. 1988 Aug 13;2(8607):361-5 - PubMed
  32. Lancet. 1987 Dec 26;2(8574):1481-3 - PubMed
  33. Lancet. 1981 Feb 28;1(8218):459-61 - PubMed
  34. Clin Sci (Lond). 1986 Dec;71(6):665-73 - PubMed
  35. Lancet. 1979 Oct 6;2(8145):705-9 - PubMed
  36. N Engl J Med. 1990 May 3;322(18):1265-71 - PubMed
  37. BMJ. 1990 Apr 21;300(6731):1056-60 - PubMed
  38. Clin Sci (Lond). 1982 Mar;62(3):329-36 - PubMed
  39. Br Med J (Clin Res Ed). 1987 Dec 5;295(6611):1441-4 - PubMed
  40. J Bone Miner Res. 1987 Dec;2(6):491-6 - PubMed
  41. N Engl J Med. 1992 Jul 9;327(2):82-7 - PubMed
  42. Metabolism. 1989 Mar;38(3):238-42 - PubMed
  43. Lancet. 1980 Nov 29;2(8205):1151-4 - PubMed
  44. J Reprod Med. 1982 Aug;27(8 Suppl):511-4 - PubMed
  45. Br Med J. 1977 Sep 24;2(6090):789-92 - PubMed
  46. Clin Pharmacol Ther. 1976 Nov;20(5):593-604 - PubMed
  47. Lancet. 1990 Aug 4;336(8710):265-9 - PubMed
  48. Ann Intern Med. 1977 Dec;87(6):649-55 - PubMed
  49. J Clin Invest. 1989 Mar;83(3):1073-7 - PubMed
  50. N Engl J Med. 1990 Jul 12;323(2):73-9 - PubMed
  51. Calcif Tissue Int. 1988 Feb;42(2):77-86 - PubMed
  52. J Clin Endocrinol Metab. 1982 Dec;55(6):1124-30 - PubMed
  53. Ann Intern Med. 1987 Jan;106(1):40-5 - PubMed
  54. Obstet Gynecol. 1990 Aug;76(2):290-5 - PubMed
  55. BMJ. 1989 Jan 21;298(6667):137-40 - PubMed
  56. N Engl J Med. 1980 Nov 20;303(21):1195-8 - PubMed
  57. BMJ. 1989 Apr 8;298(6678):924-8 - PubMed
  58. J Bone Miner Res. 1989 Apr;4(2):223-5 - PubMed
  59. Ann Intern Med. 1985 Mar;102(3):319-24 - PubMed
  60. Calcif Tissue Int. 1988 Feb;42(2):71-6 - PubMed

MeSH terms

Publication Types

LinkOut - more resources